FDA Adverse Event Injury Summary report: N

PHILIPS RESPIRONICS CPAP RNTCPAP5

MDR report key: 12294174 · Received August 6, 2021

Report

Report Number
MW5103088
Event Type
Injury
Date Received
August 6, 2021
Date of Event
October 9, 2020
Report Date
August 4, 2021
Manufacturer
PHILIPS RESPIRONICS / RESPIRONICS, INC.
Product Code
BZD
Adverse Event
Yes
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
WI, US
Reporter Occupation
PATIENT

Narratives

Description of Event or Problem · 1

BLOOD CANCER - MPN; THE PHILIPS RESPIRONICS CPAP DEVICE THAT I USED SINCE (B)(6) 2017 FOR SLEEP APNEA HAS ISSUED A RECALL, DUE TO POTENTIAL RISKS RELATED TO THE FOAM USED TO REDUCE THE SOUND AND VIBRATION OF THE MOTOR. ONE OF THE RISKS IS POTENTIAL CANCER CAUSED FROM THE TOXIC GASES. I WAS DIAGNOSED WITH MYELOPROLIFERATIVE NEOPLASM IN (B)(6) 2020. FDA SAFETY REPORT ID # (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1188747 PHILIPS RESPIRONICS CPAP RNTCPAP5 VENTILATOR, NON-CONTINUOUS (RESPIRATOR) BZD PHILIPS RESPIRONICS / RESPIRONICS, INC. RNTCPAP DREAMSTATION

Patients

Seq Age Sex Outcome Treatment
1 62 YR Other